Get Details

Every Day Matters

We are developing tumor-activated immunotherapies precision-engineered to transform the lives of patients so they can focus on what counts.

Learn more

Every Day Matters

We are developing tumor-activated immunotherapies precision-engineered to transform the lives of patients so they can focus on what counts.
Learn more
We are a developing tumor-activated immunotherapies precision-engineered to transform the lives of patients so they can focus on what counts.
Learn more
 

Our bispecific molecules are designed to stimulate the immune system within the tumor microenvironment without causing systemic safety issues.

X

Our Programs

Our current development programs are focused on selectively modulating T cells to fight cancer.

hp_cc_pipeline
hp_cc_clinical_trials

Our Clinical Trials

Our first clinical trial is evaluating our lead tumor-activated T cell engager (TRACTr) to address prostate cancer.

Want to work in a fast-paced and dynamic team environment? Join us!